JSR Life Sciences to Transfer Crown Bioscience to Adicon

JSR Life Sciences entered a definitive agreement to transfer Crown Bioscience to Adicon Holdings Limited, according to a statement.

• Crown Bioscience’s Global Biospecimens business will remain fully integrated within JSR Life Sciences
• The transaction is expected to close in 2026
• Crown Bioscience will operate as a standalone entity under Adicon’s ownership

To view the source of this information click here

This story was produced with the assistance of Bloomberg automation

To contact the reporter on this story:
Dayana Mustak in London at nmustak@bloomberg.net

To contact the editor responsible for this story:
Sachin Ravikumar at sravikumar6@bloomberg.net

© 2025 Bloomberg L.P. All ...